Electromed, Inc.

AMEX:ELMD

Medical - Devices

Healthcare
$23.40 +1.16%

+$0.43 today

Market cap
$191.27M
Beta
0.52
P/E (TTM)
30.5
EPS (TTM)
$1.23
52W Low $17.73High $40.00

Volume 0.05M

Average 0.06M

ELMD EBITDA Margin

EBITDA as a percentage of revenue.

Electromed, Inc.AMEX: ELMD

EBITDA Margin · Q3 FY2026 · quarter ended Mar 2026

EBITDA Margin widens to 22.4%

EBITDA Margin was 22.4% in Q3 FY2026, up 6.0 pp from a year earlier. On a trailing-twelve-month basis it was 20.6%, up 3.4 pp year over year. Over 3 fiscal years it widened by 9.2 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 2 analysts of 20.4% for the fiscal year ending Jun 2026, up from 17.9% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterMar 2026
22.4%+1.3 pp QoQ
Last fiscal yearJun 2025
17.9%+3.5 pp YoY
LTMMar 2026
20.6%+3.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter+6.0 pp-0.2 pp-6.2 pp
1 year+3.5 pp+2.5 pp-1.0 pp
3 years+9.2 pp+5.6 pp-3.6 pp
5 years-0.8 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
17.9%
Year-over-year change
+3.5pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How ELMD compares with its peers on the latest reported figures

  • ELMD's LTM Mar 2026 EBITDA Margin of 20.6% is the 2nd highest of the 6 companies compared; the peer median is 16.2%.
  • Its year-over-year change of +3.4 pp is the 2nd highest of 6, against a peer median of +0.8 pp.
  • Over three fiscal years its change of +9.2 pp compares with a peer median of +5.9 pp.
ELMD Competitors Peer median
EBITDA Margin for ELMD and competitors
Company Period LTM level YoY 3-year change
RMDResMed Inc.LTM Jun 202638.3% +1.0 pp+5.9 pp
ELMDElectromed, Inc.LTM Mar 202620.6% +3.4 pp+9.2 pp
VMDViemed Healthcare, Inc.LTM Mar 202618.5% +0.7 pp+1.2 pp
AHCOAdaptHealth Corp.LTM Apr 202616.2% -7.4 pp-5.7 pp
TCMDTactile Systems Technology, Inc.LTM Mar 202612.1% +0.8 pp+11.1 pp
LUNGPulmonx CorporationLTM Mar 2026-54.5% +6.4 pp+50.0 pp
Peer median (excluding ELMD) 16.2%+0.8 pp+5.9 pp

Competitors are the stored peer set for ELMD. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Jun 2021
FY2022
Jun 2022
FY2023
Jun 2023
FY2024
Jun 2024
FY2025
Jun 2025
Revenue35.76M41.66M48.07M54.72M64M
Cost of Revenue8.45M10.22M11.55M12.99M14.03M
Gross Profit27.31M31.44M36.52M41.73M49.97M
Gross Margin76.4%75.5%76.0%76.3%78.1%
Research & Development1.72M1.36M916K656K996K
Selling, General & Admin22.44M27.11M31.6M34.49M39.1M
Operating Expenses24.17M28.47M32.51M35.15M40.1M
Depreciation & Amortization610K628K613K841K1.17M
EBITDA3.78M3.63M4.7M7.88M11.46M
EBITDA Margin10.6%8.7%9.8%14.4%17.9%
Operating Income3.14M2.97M4.01M6.58M9.87M
Operating Margin8.8%7.1%8.3%12.0%15.4%
Interest Income39K25K78K455K624K
Interest Expense00000
Other Income / Expenses27K25K78K455K412K
Income Before Tax3.17M3M4.09M7.04M10.28M
Pre-Tax Margin8.9%7.2%8.5%12.9%16.1%
Income Tax Expense805K692K920K1.89M2.75M
Net Income2.36M2.31M3.17M5.15M7.54M
Net Margin6.6%5.5%6.6%9.4%11.8%
EPS (Basic)0.280.270.370.600.90
EPS (Diluted)0.270.260.360.580.86
Weighted Avg Shares8.57M8.47M8.46M8.56M8.33M
Weighted Avg Shares (Diluted)8.91M8.77M8.7M8.86M8.72M

Electromed, Inc.

AMEX:ELMD

Intrinsic Alpha fair value

Locked

Current Price

$23.40

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.